Tegsedi Drug Interactions
Currently displaying a list of 237 drugs known to interact with Tegsedi (inotersen).
- 183 major drug interactions
- 54 moderate drug interactions
Medications known to interact with Tegsedi
Note: Showing generic names only.
- abciximab
- acalabrutinib
- acyclovir
- adefovir
- ado-trastuzumab emtansine
- aldesleukin
- alteplase
- amikacin
- amikacin liposome
- amphotericin b
- amphotericin b cholesteryl sulfate
- amphotericin b lipid complex
- amphotericin b liposomal
- anagrelide
- anisindione
- anistreplase
- antithrombin (recombinant)
- antithrombin iii
- apixaban
- ardeparin
- argatroban
- aspirin
- avapritinib
- bacitracin
- balsalazide
- bedaquiline
- betrixaban
- binimetinib
- bivalirudin
- black cohosh
- botulism immune globulin
- brentuximab
- bromfenac
- bromfenac ophthalmic
- cabozantinib
- cangrelor
- cannabidiol
- caplacizumab
- capreomycin
- carboplatin
- celecoxib
- cidofovir
- cilostazol
- cisplatin
- citalopram
- clofarabine
- clomipramine
- clopidogrel
- colistimethate
- cyclophosphamide
- cyclosporine
- cytomegalovirus immune globulin
- dabigatran
- daclizumab
- dalteparin
- danaparoid
- dasatinib
- deferasirox
- deferoxamine
- defibrotide
- deoxycholic acid
- desirudin
- desvenlafaxine
- dexfenfluramine
- diatrizoate
- diclofenac
- diclofenac ophthalmic
- diclofenac topical
- dicumarol
- diflunisal
- dimethyl fumarate
- dipyridamole
- diroximel fumarate
- drotrecogin alfa
- duloxetine
- edetate calcium disodium
- edetate disodium (edta)
- edoxaban
- efavirenz
- encorafenib
- enoxaparin
- entecavir
- epirubicin
- epoprostenol
- eptifibatide
- escitalopram
- etidronate
- etodolac
- everolimus
- exenatide
- fedratinib
- fenfluramine
- fenoprofen
- flucytosine
- fluoxetine
- flurbiprofen
- flurbiprofen ophthalmic
- fluvoxamine
- fondaparinux
- foscarnet
- ibandronate
- ibritumomab
- ibrutinib
- ibuprofen
- idelalisib
- ifosfamide
- iloprost
- immune globulin intravenous
- immune globulin intravenous and subcutaneous
- indomethacin
- interferon beta-1a
- interferon beta-1b
- iobenguane I 131
- iodamide
- iodine i 131 tositumomab
- iodipamide
- iodixanol
- iohexol
- iomeprol
- iopamidol
- iopromide
- iothalamate
- ioversol
- ioxaglate
- ioxilan
- leflunomide
- lepirudin
- levomilnacipran
- lifileucel
- lithium
- lomitapide
- lutetium lu 177 dotatate
- lutetium lu 177 vipivotide tetraxetan
- meclofenamate
- mefenamic acid
- meloxicam
- mesalamine
- methotrexate
- methoxyflurane
- metrizamide
- milnacipran
- mipomersen
- monomethyl fumarate
- moxetumomab pasudotox
- pamidronate
- panobinostat
- paroxetine
- peginterferon beta-1a
- pemetrexed
- penicillamine
- pentamidine
- pentosan polysulfate sodium
- pentoxifylline
- phenylbutazone
- piroxicam
- plazomicin
- plicamycin
- polymyxin b
- ponatinib
- prasugrel
- ramucirumab
- regorafenib
- remdesivir
- respiratory syncytial virus immune globulin
- reteplase
- rho (d) immune globulin
- rivaroxaban
- rofecoxib
- ruxolitinib
- salsalate
- sertraline
- sibutramine
- sirolimus
- streptokinase
- streptomycin
- streptozocin
- sulfasalazine
- sulfinpyrazone
- sulindac
- suprofen ophthalmic
- tacrolimus
- tazemetostat
- telavancin
- telbivudine
- temsirolimus
- tenecteplase
- tenofovir alafenamide
- tenofovir disoproxil
- teriflunomide
- thioguanine
- ticagrelor
- ticlopidine
- tinzaparin
- tipranavir
- tirofiban
- tobramycin
- tolmetin
- tositumomab
- tovorafenib
- trabectedin
- treprostinil
- turmeric
- valacyclovir
- valdecoxib
- valganciclovir
- vancomycin
- venlafaxine
- vilazodone
- voclosporin
- vorapaxar
- vortioxetine
Tegsedi disease interactions
There are 5 disease interactions with Tegsedi (inotersen) which include:
More about Tegsedi (inotersen)
- Tegsedi consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Vyndamax
Vyndamax may be given to reduce death or hospitalization caused by heart problems in adults with ...
Vyndaqel
Vyndaqel (tafamidis meglumine) is a transthyretin stabilizer that may be given to reduce death or ...
Onpattro
Onpattro is used to treat polyneuropathy in adults with hereditary transthyretin-mediated ...
Wainua
Wainua (eplontersen) is used to treat polyneuropathy of hereditary transthyretin-mediated ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Vutrisiran
Vutrisiran is used to treat adults with nerve damage (polyneuropathy) caused by hereditary ...
Eplontersen
Eplontersen (Wainua) is used to treat polyneuropathy of hereditary transthyretin-mediated ...
Patisiran
Patisiran (brand name Onpattro) is an injectable treatment for polyneuropathy caused by hereditary ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.